Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020

SELL
$7.49 - $15.16 $358,022 - $724,648
-47,800 Reduced 84.15%
9,000 $136,000
Q2 2019

Aug 14, 2019

SELL
$17.79 - $22.88 $56,928 - $73,216
-3,200 Reduced 5.33%
56,800 $1.3 Million
Q1 2019

May 13, 2019

BUY
$11.76 - $22.15 $81,144 - $152,835
6,900 Added 12.99%
60,000 $0
Q4 2017

Feb 13, 2018

BUY
$18.0 - $30.0 $955,800 - $1.59 Million
53,100
53,100 $1.39 Million

Others Institutions Holding AXDX

About Accelerate Diagnostics, Inc


  • Ticker AXDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 99,059,904
  • Market Cap $191M
  • Description
  • Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...
More about AXDX
Track This Portfolio

Track Sculptor Capital LP Portfolio

Follow Sculptor Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sculptor Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Sculptor Capital LP with notifications on news.